Global Drug Device Combination Products Market Projected to Hit $379.17 Billion by 2030

According to MarketsandMarkets™, The report ” Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region – Global Forecast to 2030 “global drug device combination products market is projected to reach USD 379.17 billion by 2030 from USD 243.02 billion in 2025, at a CAGR of 9.3%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131140423

Browse

• 299 Market Data Tables
• 64 Figures
• 345 Pages and in-depth TOC on “ Drug Device Combination Products Market – Global Forecast to 2030”.

Some of the prominent key players are:

• Abbott (US),
• Boston Scientific Corporation (US),
• Medtronic (Ireland),
• Becton, Dickinson and Company (US),
• Novartis AG (Switzerland),
• Novo Nordisk A/S (Denmark),
• Sanofi (France), and many more…..

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Drug Device Combination Products Market.

Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=131140423

• The market for drug-device combination products can be categorized primarily by product type into injectable drug delivery devices, drug-eluting stents, inhalers, infusion pumps, transdermal patches, drug-eluting balloon catheters, and other product types. Among these, injectable drug delivery devices hold the predominant market share.
• The drug-device combination products market is categorized based on end-users into several segments: hospitals & clinics, ambulatory surgery centers, long-term care facilities, home care settings, and other users. In 2024, the home care segment accounted for the highest CAGR during the forecast period due to the escalating incidence of chronic conditions, demographic shifts with an aging population, the increasing feasibility of self-administration, technological advancements, and favorable reimbursement policies.
• The drug-device combination products market is categorized by region into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds a significant share of this market, primarily driven by the growing geriatric population and the rising prevalence of chronic diseases.

The global burden of chronic diseases, particularly diabetes and obesity, alongside an increasingly aging population, is expected to significantly drive the demand for drug-device combination products. This trend is further supported by a heightened emphasis on patient-centric design principles, coupled with government initiatives aimed at improving affordability and accessibility. Investments in R&D for innovative product solutions, along with a rising adoption of home care settings and self-administration practices, are likely to bolster market growth during the forecast period. These developments are anticipated to enhance the utility and efficiency of drug-device combinations. However, challenges such as the need for alternative drug delivery systems and the prevalent lack of patient training and education may pose obstacles to the growth of the drug-device combination products market.

Related Reports:

Infusion Pump Market – Global Forecast to 2030

Autoinjectors Market– Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com